Recap: Personalis Q2 Earnings

Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 17.24% year over year to ($0.34), which beat the estimate of ($0.39).

Revenue of $21,670,000 higher by 11.16% from the same period last year, which beat the estimate of $21,210,000.

Guidance

Personalis Sees Q3 Sales ~$22.2M Vs. $22.16M Est., FY21 Sales ~$85M Vs. $85.23M

How To Listen To The Conference Call

Date: Aug 04, 2021

Time: 05:00 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/6cagse9c

Recent Stock Performance

52-week high: $53.46

52-week low: $17.09

Price action over last quarter: down 8.92%

Company Profile

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions.

Grindr Earlier Reported H1 2022 Earnings Before IPO, Non-GAAP Revenue Was ~$90M And H1’22 Adjusted EBITDA Was ~$42M For Representing A Period-Over-Period Growth Of 44% In Non-GAAP Revenue And 26% In Adjusted EBITDA

Grindr announces the closing of business combination with Tiga Acquisition Corp. Grindr is a profitable leader in the world of LGBTQ social networking platforms with a highly engaged user base in a large and untapped addressable market ("TAM") of estimated $4 billion for 2022 and serving a highly coveted audience

Green Plains: Q4 Earnings Insights

Green Plains (NASDAQ:GPRE) reported its Q4 earnings results on Friday, February 11, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Green Plains reported earnings of $-0.18.